Volume 155, Issue 5, Pages e3 (November 2018)

Slides:



Advertisements
Similar presentations
Volume 138, Issue 1, Pages e1 (January 2010)
Advertisements

Volume 150, Issue 2, Pages e6 (February 2016)
Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants  Jacqueline G. O'Leary, Carmen Landaverde,
Donor age still matters in liver transplantation
Challenges to Liver Transplantation and Strategies to Improve Outcomes
Volume 152, Issue 4, Pages (March 2017)
Volume 147, Issue 1, Pages (July 2014)
Community Colonoscopy: A Gordian Knot?
Volume 144, Issue 5, Pages (May 2013)
Volume 146, Issue 5, Pages e1 (May 2014)
Volume 137, Issue 5, Pages e2 (November 2009)
Covering the Cover Gastroenterology
Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery  Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.
Outcomes Among Living Liver Donors
Unusual Cause of Elevated Liver Enzymes in a Female Patient
Volume 145, Issue 4, Pages e4 (October 2013)
New Model for End Stage Liver Disease Improves Prognostic Capability After Transjugular Intrahepatic Portosystemic Shunt  Jennifer Guy, Ma Somsouk, Stephen.
Volume 140, Issue 7, Pages (June 2011)
Roberts Brown, Jean C. Emond  Gastroenterology 
Cause-Specific Mortality of People With Barrett's Esophagus Compared With the General Population: A Population-Based Cohort Study  Masoud Solaymani–Dodaran,
Volume 137, Issue 5, Pages (November 2009)
Volume 154, Issue 8, Pages e8 (June 2018)
Volume 137, Issue 3, Pages e1 (September 2009)
Yi-An Pan, Ivy Yenwen Chau, Gar-Yang Chau  Gastroenterology 
Volume 146, Issue 4, Pages e1 (April 2014)
The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?
Volume 155, Issue 2, Pages e17 (August 2018)
Volume 149, Issue 6, Pages e1 (November 2015)
Volume 153, Issue 3, Pages e16-e17 (September 2017)
Volume 150, Issue 4, Pages (April 2016)
Volume 154, Issue 4, Pages e7 (March 2018)
Volume 154, Issue 4, Pages (March 2018)
Volume 155, Issue 5, Pages (November 2018)
Sonia Radunz, Hideo A. Baba, Georgios C. Sotiropoulos  Gastroenterology 
A Rare Cause of Postprandial Abdominal Pain and Nausea
Current and Future Trends in Liver Transplantation in Europe
Challenges to Liver Transplantation and Strategies to Improve Outcomes
Volume 152, Issue 5, Pages e1 (April 2017)
A. Sidney Barritt, Michael W. Fried  Gastroenterology 
Volume 134, Issue 5, Pages (May 2008)
Rawad Mounzer, Shahid M. Malik, John Nasr, Bahar Madani, Michael E
Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States  Ju Dong Yang, Joseph.
Volume 138, Issue 1, Pages e1 (January 2010)
Ingmar Mederacke, Michael P. Manns, Bernhard Meyer  Gastroenterology 
Covering the Cover Gastroenterology
Coffee and Colorectal Cancer: Grounds for Prevention?
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis  Atsushi Tanaka, Susumu Tazuma, Kazuichi Okazaki, Takahiro.
Eric S. Orman, Marwan Ghabril, Naga Chalasani 
Volume 133, Issue 2, Pages (August 2007)
Recurrent Hematochezia in a Patient With Chronic Constipation
Covering the Cover Gastroenterology
Amer A. Alkhatib, MD, Rodney W. Stuart, MD, Ronald L. Weiss, MD 
Volume 149, Issue 6, Pages (November 2015)
Issue Highlights Clinical Gastroenterology and Hepatology
Donor Race Does Not Predict Graft Failure After Liver Transplantation
Volume 142, Issue 6, Pages e4 (May 2012)
Hsuan-An Su, Hui-Ting Hsu, Hsu-Heng Yen  Gastroenterology 
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 156, Issue 5, Pages e3 (April 2019)
Volume 138, Issue 6, Pages (May 2010)
Volume 152, Issue 5, Pages e1 (April 2017)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Volume 143, Issue 5, Pages (November 2012)
Electronic Clinical Challenges and Images in GI
Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants  Jacqueline G. O'Leary, Carmen Landaverde,
Controversies in Liver Transplantation for Hepatitis C
Adverse Outcomes: Why Bad Things Happen to Good People
Volume 135, Issue 5, Pages (November 2008)
Presentation transcript:

Volume 155, Issue 5, Pages 1451-1462.e3 (November 2018) Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease–Sodium Scores on Patient Outcomes  Shunji Nagai, Lucy C. Chau, Randolph E. Schilke, Mohamed Safwan, Michael Rizzari, Kelly Collins, Atsushi Yoshida, Marwan S. Abouljoud, Dilip Moonka  Gastroenterology  Volume 155, Issue 5, Pages 1451-1462.e3 (November 2018) DOI: 10.1053/j.gastro.2018.07.025 Copyright © 2018 AGA Institute Terms and Conditions

Gastroenterology 2018 155, 1451-1462. e3DOI: (10. 1053/j. gastro. 2018 Copyright © 2018 AGA Institute Terms and Conditions

Figure 1 (A) Score distribution at registration. (B) Score distribution at transplantation. (C) Comparisons of serum sodium concentration at transplantation according to score category. Gastroenterology 2018 155, 1451-1462.e3DOI: (10.1053/j.gastro.2018.07.025) Copyright © 2018 AGA Institute Terms and Conditions

Figure 2 Comparison of waitlist and post-transplantation outcomes between the MELD and MELD-Na periods (reference, MELD period; *P < .05). (A) HR for 90-day waitlist mortality in the MELD-Na period according to score categories. (B) HR for 90-day transplantation probability in the MELD-Na period according to score categories. (C) HR for 1-year liver graft loss in the MELD-Na period according to score range categories. Gastroenterology 2018 155, 1451-1462.e3DOI: (10.1053/j.gastro.2018.07.025) Copyright © 2018 AGA Institute Terms and Conditions

Figure 3 Comparison of cumulative incidence of waitlist mortality and transplantation between propensity score matched groups by period. (A) Cumulative incidence of waitlist mortality and transplantation. (B) Standardized difference before and after matching. The model achieved a standardized difference less than 0.10 (10%) after matching for all covariates. Gastroenterology 2018 155, 1451-1462.e3DOI: (10.1053/j.gastro.2018.07.025) Copyright © 2018 AGA Institute Terms and Conditions

Figure 4 Risk of hyponatremia for 90-day waitlist mortality in the MELD and MELD-Na periods (reference, normal sodium concentration [135–145 mmol/L]; *P < .05). (A) HR of mild hyponatremia (130–134 mmol/L) in MELD period. (B) HR of moderate hyponatremia (125–129 mmol/L) in MELD period. (C) HR of severe hyponatremia (<125 mmol/L) in MELD period. (D) HR of mild hyponatremia (130–134 mmol/L) in MELD-Na period. (E) HR of moderate hyponatremia (125–129 mmol/L) in MELD-Na period. (F) HR of severe hyponatremia (<125 mmol/L) in MELD-Na period. Gastroenterology 2018 155, 1451-1462.e3DOI: (10.1053/j.gastro.2018.07.025) Copyright © 2018 AGA Institute Terms and Conditions

Figure 5 Comparison of mortality risk in MELD-Na vs MELD period. Mortality risk by MELD and MELD-Na scores for liver transplant recipients was compared with that of patients on the LT waitlist. The columns showed HRs and P values by classifying the patients based on their final scores. Columns highlighted in light blue, gray, and orange represent “not favoring transplantation” (staying on the waitlist), “comparable,” and “favoring transplantation.” The transition point justifying survival benefit of LT shifted toward a higher score category. (A) Waitlist death includes “mortality” only. (B) Waitlist death includes “mortality” and “removal because too sick for transplantation.” Gastroenterology 2018 155, 1451-1462.e3DOI: (10.1053/j.gastro.2018.07.025) Copyright © 2018 AGA Institute Terms and Conditions

Supplementary Figure 1 Comparison of waitlist and post-transplantation outcomes between MELD and MELD-Na periods (reference, MELD period; *P < .05). (a) HR for overall waitlist mortality in MELD-Na period according to score categories. (b) HR for overall transplantation probability in MELD-Na period according to score categories. Gastroenterology 2018 155, 1451-1462.e3DOI: (10.1053/j.gastro.2018.07.025) Copyright © 2018 AGA Institute Terms and Conditions

Supplementary Figure 2 Comparison of cumulative incidence of transplantation and waitlist mortality. (a) Patients whose initial and final MELD score was lower than 15 but whose MELD-Na score was at least 15. (b) Patients whose initial MELD score was lower than 35 but whose MELD-Na score was at least 35. (c) Patients with initial MELD and MELD-Na scores of at least 35. Gastroenterology 2018 155, 1451-1462.e3DOI: (10.1053/j.gastro.2018.07.025) Copyright © 2018 AGA Institute Terms and Conditions